Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates.
by Marci A. Landsmann
The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types.
by Anna Azvolinsky
Going through cancer treatment and ensuing complications is never easy, but surrounding yourself with the right key players can help, writes pancreatic cancer survivor Rob Weker.
by Rob Weker
Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.
by Marcus A. Banks
To gain control over fear of my breast cancer recurring, I called on lessons learned as a 5-year-old confronting the neighborhood bully.
by Joan Harris
Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex.
by Kendall K. Morgan
Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.
by Lindsey Konkel
A therapeutic vaccine targeting advanced cervical cancer.
Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
by Sharon Tregaskis
Medical histories capture a vital snapshot of a patient’s health status. In his new book, hematologist-oncologist Mikkael A. Sekeres provides a richer narrative.
Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge.
by Ashley P. Taylor
A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials.
by Emma Yasinski
This genome editing system allows researchers to accurately delete, add or modify specific regions of the genome.
The leading cause of liver cancer is infection with the hepatitis B virus or the hepatitis C virus.
The passing of Alex Trebek has brought pancreatic cancer into the public consciousness.
Learning Medicare’s ABCDs
donate to the AACR